Inspire Medical Systems(INSP)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

INSP Inspire Medical Systems

交易中 10-19 11:31:25 EDT

69.42

+0.63

+0.92%

最高70.00	最低68.44	成交量8.68万
今开68.97	昨收68.79	日振幅2.27%
总市值19.99亿	流通市值16.16亿	总股本2,880万
成交额599.50万	换手率0.37%	流通股本2,328万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"INSP","market":"US","secType":"STK","nameCN":"Inspire Medical Systems","latestPrice":69.42,"timestamp":1792423876559,"preClose":68.79,"halted":0,"volume":86817,"delay":0,"changeRate":0.009158307893589117,"floatShares":23277800,"shares":28797307,"eps":4.607234,"marketStatus":"交易中","change":0.63,"latestTime":"10-19 11:31:25 EDT","open":68.97,"high":70,"low":68.44,"amount":5994984.719040001,"amplitude":0.022678,"askPrice":69.52,"askSize":2,"bidPrice":69.31,"bidSize":15,"shortable":3,"etf":0,"ttmEps":4.607234,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1792440000000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1525320000000,"exchange":"NYSE","adjPreClose":68.79,"preHourTrading":{"tag":"盘前","latestPrice":69.3997,"preClose":68.79,"latestTime":"09:20 EDT","volume":2858,"amount":197631.72888,"timestamp":1792416000548,"change":0.6097,"changeRate":0.008863,"amplitude":0.056404},"postHourTrading":{"tag":"盘后","latestPrice":68.79,"preClose":68.79,"latestTime":"19:30 EDT","volume":94684,"amount":6513311.47,"timestamp":1792193404630,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.344942,"impliedVol":0.8252,"impliedVolPercentile":0.7092},"requestUrl":"/m/hq/s/INSP","defaultTab":"news","newsList":[{"id":"1159767688","title":"Inspire Medical Systems预计重组相关行动大部分将在第三季度完成","url":"https://stock-news.laohu8.com/highlight/detail?id=1159767688","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1159767688?lang=zh_cn&edition=full","pubTime":"2026-08-04 04:05","pubTimestamp":1785787510,"startTime":"0","endTime":"0","summary":"Inspire Medical Systems公司表示，其与重组有关的多数行动，有望在第三季度内悉数收尾。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065731478.USD","BK4167","BK4082","INSP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150034270","title":"Inspire Medical Systems发布2026年第二季度财报，上调全年指引并披露战略增长蓝图","url":"https://stock-news.laohu8.com/highlight/detail?id=1150034270","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1150034270?lang=zh_cn&edition=full","pubTime":"2026-08-04 04:03","pubTimestamp":1785787391,"startTime":"0","endTime":"0","summary":"Inspire Medical Systems公司（股票代码：INSP）正式揭晓了其2026年第二季度的财务业绩。伴随着这一季报的出炉，管理层不仅同步上调了全年的业绩展望，还对外阐述了一项旨在驱动未来发展的战略性增长计划。这些举措共同描绘了这家医疗科技企业当前强劲的经营态势与对未来的积极预期。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INSP","BK4167","BK4082","LU2065731478.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190947494","title":"瑞银首评Inspire Medical Systems：给予卖出评级，目标价39美元，此前为中性，目标价67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1190947494","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1190947494?lang=zh_cn&edition=full","pubTime":"2026-07-28 18:35","pubTimestamp":1785234909,"startTime":"0","endTime":"0","summary":"瑞银（UBS）首次覆盖Inspire Medical Systems，给予“卖出”评级，与之前的“中性”评级形成对照；其设定的目标价为39美元，而此前目标价为67美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INSP","BK4167","LU2065731478.USD","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104540656","title":"财报前瞻 ｜Inspire Medical Systems本季度营收或小幅下滑，机构观点偏谨慎","url":"https://stock-news.laohu8.com/highlight/detail?id=1104540656","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1104540656?lang=zh_cn&edition=full","pubTime":"2026-07-27 11:00","pubTimestamp":1785121237,"startTime":"0","endTime":"0","summary":"Inspire Medical Systems将于2026年08月03日发布最新季度财报，市场关注营收与利润率走向及EPS波动。上季度Inspire Medical Systems营收为2.05亿美元，同比增长1.62%；毛利率为86.47%；归属于母公司的净利润为-1,129.40万美元，净利率为-5.52%；调整后每股收益为-0.39美元，同比下降490.00%。在近六个月的机构动态中，偏谨慎的声音占比更高，主要围绕本季度营收可能小幅下滑与EPS亏损扩大的担忧展开。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"财报前瞻 ｜Inspire Medical Systems本季度营收或小幅下滑，机构观点偏谨慎","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INSP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108826723","title":"Evercore ISI将Inspire Medical Systems评级从“跑赢大盘”下调至“与大市同步”，目标价从55美元大幅削减至40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1108826723","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1108826723?lang=zh_cn&edition=full","pubTime":"2026-06-23 18:20","pubTimestamp":1782210049,"startTime":"0","endTime":"0","summary":"Evercore ISI对Inspire Medical Systems Inc (INSP) 的投资评级进行了调整，将其从原先的“跑赢大盘”下调至“与大市同步”。与此同时，该机构显著调低了该股的目标价，从每股55美元大幅削减至40美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4167","INSP","LU2065731478.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149052778","title":"美国银行全球研究下调Inspire Medical Systems评级至\"跑输大盘\"，目标价大幅削减至39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1149052778","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1149052778?lang=zh_cn&edition=full","pubTime":"2026-05-22 21:37","pubTimestamp":1779457035,"startTime":"0","endTime":"0","summary":"美国银行全球研究发布最新评级报告，将睡眠呼吸障碍治疗设备公司Inspire Medical Systems的投资评级从\"中性\"大幅下调至\"跑输大盘\"。与此同时，分析师团队将其目标股价从原先的53美元显著调降至39美元，降幅超过26%，显示出对该股未来表现的谨慎预期。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INSP","BK4167","LU2065731478.USD","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159172947","title":"Inspire Medical Systems评级遭下调：Piper Sandler从增持降至中性，目标价从85美元腰斩至55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1159172947","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1159172947?lang=zh_cn&edition=full","pubTime":"2026-05-05 22:00","pubTimestamp":1777989609,"startTime":"0","endTime":"0","summary":"医疗设备公司Inspire Medical Systems遭遇投资机构评级下调。Piper Sandler宣布将其投资评级从\"增持\"下调至\"中性\"，同时大幅削减目标股价——从原先的85美元骤降至55美元，降幅超过35%。\n此次调整反映出市场对该公司短期增长前景的谨慎态度。分析师指出，尽管Inspire Medical Systems在睡眠呼吸暂停治疗领域具备技术优势，但当前估值水平已充分反映其增长潜力。目标价的大幅下调预示着机构对其未来盈利能力的预期有所降温。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065731478.USD","INSP","BK4082","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190817457","title":"Inspire Medical Systems评级遭美银全球研究下调至中性 目标价腰斩至53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1190817457","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1190817457?lang=zh_cn&edition=full","pubTime":"2026-05-05 18:23","pubTimestamp":1777976592,"startTime":"0","endTime":"0","summary":"美银全球研究近日将Inspire Medical Systems的投资评级从\"买入\"下调至\"中性\"，同时大幅调降其目标价，从120美元削减至53美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065731478.USD","BK4167","BK4082","INSP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111339875","title":"异动解读 | 多家投行下调目标价，Inspire Medical Systems盘前大跌18.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1111339875","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1111339875?lang=zh_cn&edition=full","pubTime":"2026-05-05 16:07","pubTimestamp":1777968451,"startTime":"0","endTime":"0","summary":"Inspire Medical Systems(INSP)今日盘前股价大跌18.6%，引发了市场的广泛关注。消息面上，多家华尔街投行在同一天下调了该公司的目标价。摩根大通将目标价从67美元下调至54美元，Leerink Partners将目标价从78美元下调至52美元，RBC将目标价从56美元下调至45美元，Truist Securities将目标价从64美元下调至50美元。分析师集体下调目标价通常反映了对公司未来增长前景或财务状况的担忧，这直接影响了投资者的信心，导致盘前交易中出现显著的抛售压力。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["INSP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167033828","title":"财报前瞻｜Inspire Medical Systems本季度营收预计小幅增长，机构观点偏审慎","url":"https://stock-news.laohu8.com/highlight/detail?id=1167033828","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1167033828?lang=zh_cn&edition=full","pubTime":"2026-04-27 10:40","pubTimestamp":1777257609,"startTime":"0","endTime":"0","summary":"Inspire Medical Systems将于2026年05月04日发布财报，市场预期本季度营收温和增长，但利润与EPS指标或承压。公司上季度营收2.69亿美元，同比增长12.25%；毛利率86.59%；归属于母公司股东的净利润1.36亿美元，净利率50.58%，均为同比口径；调整后每股收益1.62美元，同比增长40.87%。目前公开观点整体偏审慎占比更高，理由集中在短期利润与EPS的不确定性。多家机构认为，市场对本季度营收的温和增长已有共识，但费用投放、手术节奏与报销审批等因素可能导致EBIT与EPS阶段性承压。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"财报前瞻｜Inspire Medical Systems本季度营收预计小幅增长，机构观点偏审慎","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INSP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514331551","title":"Inspire Medical Systems, Inc.盘中异动 大幅跳水5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514331551","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514331551?lang=zh_cn&edition=full","pubTime":"2025-02-28 03:14","pubTimestamp":1740683651,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日03时14分，Inspire Medical Systems, Inc.股票出现波动，股价急速下跌5.04%。Inspire Medical Systems, Inc.股票所在的医疗器械行业中，整体跌幅为0.18%。其相关个股中，Pavmed Inc C/Wts 30/04/2025 Class Z、Lensar, Inc.、Rapid Micro Biosystems, Inc.涨幅较大，Bone Biologics Corp、Reshape Lifesciences, Inc.、Tandem Diabetes Care, Inc.较为活跃，换手率分别为29.03%、17.12%、13.85%，振幅较大的相关个股有Nexalin Technology Inc C/Wts 、Ainos Inc C/Wts 29/07/2027 、Dih Holdings Us Inc C/Wts 20/04/2028 ，振幅分别为58.93%、53.33%、45.71%。Inspire Medical Systems, Inc.公司简介：Inspire Medical Systems Inc是一家医疗技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280314119632e58d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280314119632e58d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INSP","BK4167","LU2065731478.USD","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514869254","title":"Inspire Medical Systems, Inc.盘中异动 快速上涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514869254","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514869254?lang=zh_cn&edition=full","pubTime":"2025-02-27 02:36","pubTimestamp":1740594979,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日02时36分，Inspire Medical Systems, Inc.股票出现异动，股价急速上涨5.05%。Inspire Medical Systems, Inc.股票所在的医疗器械行业中，整体涨幅为0.65%。其相关个股中，Bone Biologics Corp C/Wts 13/10/2026 、Biomerica, Inc.、Sight Sciences, Inc.涨幅较大，Venus Concept Inc.、Sintx Technologies, Inc.、Reshape Lifesciences, Inc.较为活跃，换手率分别为22.43%、20.32%、18.04%，振幅较大的相关个股有Pavmed Inc C/Wts 30/04/2025 Class Z、Inogen, Inc、Nexalin Technology Inc C/Wts ，振幅分别为44.00%、38.87%、38.28%。Inspire Medical Systems, Inc.公司简介：Inspire Medical Systems Inc是一家医疗技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227023620a2552e58&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227023620a2552e58&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","INSP","BK4167","LU2065731478.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514177418","title":"Inspire Medical Systems, Inc.盘中异动 股价大涨5.24%报186.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514177418","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514177418?lang=zh_cn&edition=full","pubTime":"2025-02-25 01:58","pubTimestamp":1740419916,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日01时58分，Inspire Medical Systems, Inc.股票出现波动，股价急速拉升5.24%。截至发稿，该股报186.62美元/股，成交量17.2906万股，换手率0.58%，振幅5.89%。Inspire Medical Systems, Inc.股票所在的医疗器械行业中，整体涨幅为0.90%。Inspire Medical Systems, Inc.公司简介：Inspire Medical Systems Inc是一家医疗技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225015836962ec446&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225015836962ec446&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2065731478.USD","BK4167","BK4082","INSP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511692153","title":"Inspire Medical Systems, Inc.2024财年实现净利润53.51百万美元，同比增加353.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511692153","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511692153?lang=zh_cn&edition=full","pubTime":"2025-02-15 00:00","pubTimestamp":1739548832,"startTime":"0","endTime":"0","summary":"2月15日，Inspire Medical Systems, Inc.公布财报，公告显示公司2024财年净利润为53.51百万美元，同比增加353.00%；其中营业收入为8.03亿美元，同比增加28.48%，每股基本收益为1.80美元。从资产负债表来看，Inspire Medical Systems, Inc.总负债1.19亿美元，其中短期债务1.75百万美元，资产负债比为6.79，流动比率为0.08。机构评级：截至2025年2月15日，当前有16家机构对Inspire Medical Systems, Inc.目标价做出预测，其中目标均价为235.88美元，其中最低目标价为190.00美元，最高目标价为280.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215000040a246150a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215000040a246150a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INSP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510330098","title":"Truist Securities：维持Inspire Medical Systems(INSP.US)评级，由买入调整至买入评级, 目标价由250.00美元调整至235.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2510330098","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510330098?lang=zh_cn&edition=full","pubTime":"2025-02-12 01:52","pubTimestamp":1739296377,"startTime":"0","endTime":"0","summary":"Truist Securities：维持Inspire Medical Systems(INSP.US)评级，由买入调整至买入评级, 目标价由250.00美元调整至235.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/12015248092604.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["INSP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196489174","title":"异动解读 | Inspire Medical Systems股价大跌6.06%,机构下调评级或目标价或为主因","url":"https://stock-news.laohu8.com/highlight/detail?id=1196489174","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1196489174?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:48","pubTimestamp":1739285319,"startTime":"0","endTime":"0","summary":"Inspire Medical Systems股价今日盘中大跌6.06%,引发了市场的广泛关注。从目前可获取的相关新闻来看,该股下跌的主要原因可能是部分机构对其发表了负面评级或目标价调整。数据显示,富国银行维持了对Inspire Medical Systems的\"持股观望\"评级,但将其目标价从198美元调整至195美元,可能反映了分析师对该股前景的小幅负面评估。总的来说,虽然Inspire Medical Systems并无重大利空消息,但因机构下调该股评级或目标价,市场情绪显现出不确定性,从而导致这一股价大幅下挫的情况出现。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"异动解读 | Inspire Medical Systems股价大跌6.06%,机构下调评级或目标价或为主因","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["INSP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510038038","title":"Inspire Medical Systems, Inc.盘中异动 早盘股价大跌6.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510038038","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510038038?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:31","pubTimestamp":1739284273,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时31分，Inspire Medical Systems, Inc.股票出现波动，股价急速下挫6.06%。Inspire Medical Systems, Inc.股票所在的医疗器械行业中，整体跌幅为0.23%。其相关个股中，Lifeward Ltd.、Inspira Technologies Oxy B.H.N. Ltd.、Trisalus Life Sciences Inc C/Wts 10/08/28 涨幅较大，Inspira Technologies Oxy B.H.N. Ltd.、Lifeward Ltd.、Beyond Air, Inc.较为活跃，换手率分别为52.79%、3.24%、1.66%，振幅较大的相关个股有Allurion Technologies, Inc.、Sight Sciences, Inc.、Pavmed Inc.，振幅分别为6.16%、5.90%、5.48%。Inspire Medical Systems, Inc.公司简介：Inspire Medical Systems Inc是一家医疗技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112231149881bcb8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112231149881bcb8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INSP","BK4167","LU2065731478.USD","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510856653","title":"富国银行：维持Inspire Medical Systems(INSP.US)评级，由持股观望调整至持股观望评级, 目标价由198.00美元调整至195.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2510856653","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510856653?lang=zh_cn&edition=full","pubTime":"2025-02-11 20:52","pubTimestamp":1739278351,"startTime":"0","endTime":"0","summary":"富国银行：维持Inspire Medical Systems(INSP.US)评级，由持股观望调整至持股观望评级, 目标价由198.00美元调整至195.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/11205248090560.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["INSP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124175797","title":"Inspire Medical Systems第四季度每股收益$1.15超出预期$0.73，销售额$2.39亿超出预期$2.37亿","url":"https://stock-news.laohu8.com/highlight/detail?id=1124175797","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1124175797?lang=zh_cn&edition=full","pubTime":"2025-02-11 05:08","pubTimestamp":1739221720,"startTime":"0","endTime":"0","summary":"Inspire Medical Systems  公布第四季度每股收益为$1.15，超出分析师预期的$0.73，高出57.53%。公司第四季度销售额为$2.3972亿，超出分析师预期的$2.37亿，高出1.14%。相比去年同期销售额$1.9251亿，同比增长24.52%。以上内容来自Benzinga Earnings专栏，原文如下：$Inspire Medical Systems$  reported quarterly earnings of $1.15 per share which beat the analyst consensus estimate of $0.73 by 57.53 percent. This is a 134.69 percent increase over earnings of $0.49 per share from the same period last year. The company reported quarterly sales of $239.72 million which beat the analyst consensus es","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Inspire Medical Systems第四季度每股收益$1.15超出预期$0.73，销售额$2.39亿超出预期$2.37亿","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INSP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509200302","title":"Inspire Medical Systems, Inc.盘中异动 快速跳水5.03%报182.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509200302","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509200302?lang=zh_cn&edition=full","pubTime":"2025-02-07 02:32","pubTimestamp":1738866735,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日02时32分，Inspire Medical Systems, Inc.股票出现异动，股价快速下跌5.03%。截至发稿，该股报182.34美元/股，成交量13.8677万股，换手率0.46%，振幅4.89%。Inspire Medical Systems, Inc.股票所在的医疗器械行业中，整体跌幅为0.39%。其相关个股中，Trisalus Life Sciences Inc C/Wts 10/08/28 、精确射线、Nevro Corp.涨幅较大，Nevro Corp.、Intelligent Bio Solutions Inc.、Sensus Healthcare, Inc.较为活跃，换手率分别为25.59%、13.02%、13.01%，振幅较大的相关个股有Tenon Medical Inc C/Wts 16/06/2028 、Hyperfine, Inc.、Intelligent Bio Solutions Inc.，振幅分别为30.81%、30.25%、19.99%。Inspire Medical Systems, Inc.公司简介：Inspire Medical Systems Inc是一家医疗技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207023215987cb164&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207023215987cb164&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4167","INSP","LU2065731478.USD","BK4082"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.inspiresleep.com","stockEarnings":[{"period":"1week","weight":-0.0015},{"period":"1month","weight":-0.0544},{"period":"3month","weight":0.3595},{"period":"6month","weight":0.1945},{"period":"1year","weight":-0.1106},{"period":"ytd","weight":-0.2541}],"compareEarnings":[{"period":"1week","weight":-0.0197},{"period":"1month","weight":0.0122},{"period":"3month","weight":0.0269},{"period":"6month","weight":0.0748},{"period":"1year","weight":0.1553},{"period":"ytd","weight":0.1193}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Inspire Medical Systems, Inc.于2007年11月在特拉华州注册成立。该公司是一家医疗技术公司，专注于为阻塞性睡眠呼吸暂停（OSA）患者开发和商业化创新的微创解决方案。该公司专有的Inspire系统是第一个也是唯一一个获得FDA批准的神经刺激技术，可为中度至重度OSA提供安全有效的治疗。该公司开发了一种新颖的闭环解决方案，可持续监测患者的呼吸，并提供轻微的舌下神经刺激，以维持开放的气道。","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.027154},{"month":2,"riseRate":0.625,"avgChangeRate":0.031099},{"month":3,"riseRate":0.25,"avgChangeRate":-0.085412},{"month":4,"riseRate":0.625,"avgChangeRate":0.049509},{"month":5,"riseRate":0.375,"avgChangeRate":-0.091314},{"month":6,"riseRate":0.666667,"avgChangeRate":0.036431},{"month":7,"riseRate":0.666667,"avgChangeRate":0.070084},{"month":8,"riseRate":0.666667,"avgChangeRate":0.073807},{"month":9,"riseRate":0.444444,"avgChangeRate":-0.040797},{"month":10,"riseRate":0.222222,"avgChangeRate":-0.026343},{"month":11,"riseRate":0.625,"avgChangeRate":0.204272},{"month":12,"riseRate":0.625,"avgChangeRate":0.019281}],"exchange":"NYSE","name":"Inspire Medical Systems","nameEN":"Inspire Medical Systems"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Inspire Medical Systems(INSP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Inspire Medical Systems(INSP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Inspire Medical Systems,INSP,Inspire Medical Systems股票,Inspire Medical Systems股票老虎,Inspire Medical Systems股票老虎国际,Inspire Medical Systems行情,Inspire Medical Systems股票行情,Inspire Medical Systems股价,Inspire Medical Systems股市,Inspire Medical Systems股票价格,Inspire Medical Systems股票交易,Inspire Medical Systems股票购买,Inspire Medical Systems股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Inspire Medical Systems(INSP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Inspire Medical Systems(INSP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}